Catalent Valuation

0C8 Stock  EUR 59.93  0.29  0.48%   
At this time, the firm appears to be undervalued. Catalent shows a prevailing Real Value of €68.88 per share. The current price of the firm is €59.93. Our model approximates the value of Catalent from analyzing the firm fundamentals such as Profit Margin of 0.09 %, return on equity of 0.0873, and Current Valuation of 11.57 B as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
59.93
Please note that Catalent's price fluctuation is very steady at this time. Calculation of the real value of Catalent is based on 3 months time horizon. Increasing Catalent's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Catalent stock is determined by what a typical buyer is willing to pay for full or partial control of Catalent. Since Catalent is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Catalent Stock. However, Catalent's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  59.93 Real  68.88 Hype  59.93 Naive  60.12
The real value of Catalent Stock, also known as its intrinsic value, is the underlying worth of Catalent Company, which is reflected in its stock price. It is based on Catalent's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Catalent's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
68.88
Real Value
69.71
Upside
Estimating the potential upside or downside of Catalent helps investors to forecast how Catalent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Catalent more accurately as focusing exclusively on Catalent's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
56.4258.5660.69
Details
Hype
Prediction
LowEstimatedHigh
59.1059.9360.76
Details
Naive
Forecast
LowNext ValueHigh
59.2960.1260.94
Details

Catalent Total Value Analysis

Catalent is presently estimated to have takeover price of 11.57 B with market capitalization of 11.84 B, debt of 4.17 B, and cash on hands of 227.9 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Catalent fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
11.57 B
11.84 B
4.17 B
227.9 M

Catalent Investor Information

About 100.0% of the company shares are owned by institutions such as pension funds. The company has Price-to-Book (P/B) ratio of 1.76. In the past many companies with similar price-to-book ratios have beat the market. Catalent has Price/Earnings To Growth (PEG) ratio of 1.17. The entity had not issued any dividends in recent years. Based on the key indicators related to Catalent's liquidity, profitability, solvency, and operating efficiency, Catalent is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Catalent Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Catalent has an asset utilization ratio of 45.95 percent. This implies that the Company is making €0.46 for each dollar of assets. An increasing asset utilization means that Catalent is more efficient with each dollar of assets it utilizes for everyday operations.

Catalent Ownership Allocation

Catalent retains a total of 180.09 Million outstanding shares. The majority of Catalent outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Catalent to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Catalent. Please pay attention to any change in the institutional holdings of Catalent as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Catalent Profitability Analysis

The company reported the revenue of 4.83 B. Net Income was 519 M with profit before overhead, payroll, taxes, and interest of 1.64 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Catalent's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Catalent and how it compares across the competition.

About Catalent Valuation

The stock valuation mechanism determines Catalent's current worth on a weekly basis. Our valuation model uses a comparative analysis of Catalent. We calculate exposure to Catalent's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Catalent's related companies.
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey. Catalent operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11000 people.

8 Steps to conduct Catalent's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Catalent's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Catalent's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Catalent's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Catalent's revenue streams: Identify Catalent's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Catalent's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Catalent's growth potential: Evaluate Catalent's management, business model, and growth potential.
  • Determine Catalent's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Catalent's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Catalent Stock analysis

When running Catalent's price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume